1
|
Joly F, Ahmed-Lecheheb D, Kalbacher E, Heutte N, Clarisse B, Grellard JM, Gernier F, Berton-Rigaud D, Tredan O, Fabbro M, Savoye AM, Kurtz JE, Alexandre J, Follana P, Delecroix V, Dohollou N, Roemer-Becuwe C, De Rauglaudre G, Lortholary A, Prulhiere K, Lesoin A, Zannetti A, N'Guyen S, Trager-Maury S, Chauvenet L, Abadie Lacourtoisie S, Gompel A, Lhommé C, Floquet A, Pautier P. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study. Ann Oncol 2019; 30:845-852. [PMID: 30851097 DOI: 10.1093/annonc/mdz074] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Few data are available on long-term fatigue (LTF) and quality of life (QoL) among epithelial ovarian cancer survivors (EOCS). In this case-control study, we compared LTF, symptoms and several QoL domains in EOCS relapse-free ≥3 years after first-line treatment and age-matched healthy women. PATIENTS AND METHODS EOCS were recruited from 25 cooperative GINECO centers in France. Controls were randomly selected from the electoral rolls. All participants completed validated self-reported questionnaires: fatigue (FACIT-F), QoL (FACT-G/O), neurotoxicity (FACT-Ntx), anxiety/depression (HADS), sleep disturbance (ISI), and physical activity (IPAQ). Severe LTF (SLTF) was defined as a FACIT-F score <37/52. Univariate and multivariate logistic regressions were conducted to analyze SLTF and its influencing factors in EOCS. RESULTS A total of 318 EOCS and 318 controls were included. EOCS were 63-year-old on average, with FIGO stage I/II (50%), III/IV (48%); 99% had received platinum and taxane chemotherapy, with an average 6-year follow-up. There were no differences between the two groups in socio-demographic characteristics and global QoL. EOCS had poorer FACIT-F scores (40 versus 45, P < 0.0001), lower functional well-being scores (18 versus 20, P = 0.0002), poorer FACT-O scores (31 versus 34 P < 0.0001), and poorer FACT-Ntx scores (35 versus 39, P < 0.0001). They also reported more SLTF (26% versus 13%, P = 0.0004), poorer sleep quality (63% versus 47%, P = 0.0003), and more depression (22% versus 13%, P = 0.01). Fewer than 20% of EOCS and controls exercised regularly. In multivariate analyses, EOCS with high levels of depression, neurotoxicity, and sleep disturbance had an increased risk of developing SLTF (P < 0.01). CONCLUSION Compared with controls, EOCS presented similar QoL but persistent LTF, EOC-related symptoms, neurotoxicity, depression, and sleep disturbance. Depression, neuropathy, and sleep disturbance are the main conditions associated with severe LTF.
Collapse
Affiliation(s)
- F Joly
- Department of Oncology, Centre François Baclesse, Caen; INSERM, U1086, Caen; UMR-S1077, University of Caen Basse-Normandie, Caen; Department of Oncology, CHU de Caen, Caen.
| | - D Ahmed-Lecheheb
- Department of Oncology, Centre François Baclesse, Caen; INSERM, U1086, Caen
| | - E Kalbacher
- Department of Oncology, CHU Jean Minjoz, Besançon
| | - N Heutte
- Department of Clinical Research, Centre François Baclesse, Caen
| | - B Clarisse
- Department of Clinical Research, Centre François Baclesse, Caen
| | - J M Grellard
- Department of Clinical Research, Centre François Baclesse, Caen
| | - F Gernier
- INSERM, U1086, Caen; Department of Clinical Research, Centre François Baclesse, Caen
| | - D Berton-Rigaud
- Department of Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Saint Herblain
| | - O Tredan
- Department of Oncology, Centre Léon Bérard, Lyon
| | - M Fabbro
- Department of Oncology, Institut Régional du Cancer, Montpellier
| | - A M Savoye
- Department of Oncology, Institut Jean Godinot, Reims
| | - J E Kurtz
- Department of Oncology, Hôpitaux Universitaires de Strasbourg, Strasbourg
| | - J Alexandre
- Department of Oncology, Hôpital Cochin, Paris
| | - P Follana
- Department of Oncology, Centre Antoine Lacassagne, Nice
| | - V Delecroix
- Department of Oncology, Clinique Mutualiste de l'Estuaire, Saint-Nazaire
| | - N Dohollou
- Department of Oncology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux
| | - C Roemer-Becuwe
- Department of Oncology, Centre d'Oncologie de Gentilly, Nancy
| | | | - A Lortholary
- Department of Oncology, Centre Catherine de Sienne, Nantes
| | - K Prulhiere
- Department of Oncology, Institut du Cancer Courlancy, Reims
| | - A Lesoin
- Department of Oncology, Centre Oscar Lambret, Lille
| | - A Zannetti
- Department of Oncology, Centre Hospitalier de Cholet, Cholet
| | | | | | - L Chauvenet
- Department of Oncology, Centre Hospitalier de Sens, Sens
| | - S Abadie Lacourtoisie
- Department of Oncology, Institut de Cancérologie de l'Ouest, Site Paul Papin, Angers
| | - A Gompel
- Department of Oncology, Hôpitaux Universitaires Cochin Hôtel-Dieu Broca, Paris
| | - C Lhommé
- Department of Oncology, Gustave Roussy, Villejuif
| | - A Floquet
- Department of Oncology, Institut Bergonié, Bordeaux, France
| | - P Pautier
- Department of Oncology, Gustave Roussy, Villejuif
| |
Collapse
|
2
|
Le Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, Peffault De Latour R, Suarez F, Bulabois C, Bay J, Chantepie S, Deconinck E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Francois S, Turlure P, Charbonnier A, Rohrlich P, N'Guyen S, Maillard N, Marchand T, Mohty M, Chevalllier P. REDUCED INTENSITY (FB2) VS REDUCED TOXICITY MYELOABLATIVE (FB3-4) FLUDARABINE/BUSULFAN-BASED CONDITIONING REGIMENS FOR NON-HODGKIN LYMPHOMA (NHL) ALLOGRAFTED PATIENTS. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_55] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | - M. Labopin
- Department of Hematology; Hôpital Saint Antoine; Paris France
| | - D. Blaise
- Centre de Recherche en Cancérologie de Marseille; Department of Hematology; Marseille France
| | - P. Ceballos
- Department of Hematology; CHU Saint Eloi; Montpellier France
| | - S. Vigouroux
- Department of Hematology, CHU de Bordeaux; Bordeaux France
| | | | - F. Suarez
- Department of Hematology; Hôpital Neker-Enfants Malades; Paris France
| | - C. Bulabois
- Department of Hematology, CHU Grenoble; Grenoble France
| | - J. Bay
- Department of Hematology, CHU de Clermont Ferrand; Clermont Ferrand France
| | | | - E. Deconinck
- Department of Hematology, CHU de Besançon; Besançon France
| | - E. Daguindau
- Department of Hematology, CHU de Besançon; Besançon France
| | - N. Contentin
- Department of Hematology, Centre Henri Becquerel; Rouen France
| | | | - J. Cornillon
- Department of Hematology; Institut de Cancérologie Lucien Neuwirth; Saint Etienne France
| | - S. Francois
- Department of Hematology, CHU Angers; Angers France
| | - P. Turlure
- Department of Hematology, CHU de Limoges; Limoges France
| | - A. Charbonnier
- Department of Hematology, CHU d'Amiens Sud; Amiens France
| | - P. Rohrlich
- Department of Hematology, CHU Nice; Nice France
| | - S. N'Guyen
- Department of Hematology; Hôpital Salpétrière; Paris France
| | - N. Maillard
- Department of Hematology; Hôpital La Miletrie; Poitiers France
| | - T. Marchand
- Department of Hematology, CHU Rennes; Rennes France
| | - M. Mohty
- Department of Hematology; Hôpital Saint Antoine; Paris France
| | | |
Collapse
|
3
|
Caluwaerts K, Staffa M, N'Guyen S, Grand C, Dollé L, Favre-Félix A, Girard B, Khamassi M. A biologically inspired meta-control navigation system for the Psikharpax rat robot. Bioinspir Biomim 2012; 7:025009. [PMID: 22617382 DOI: 10.1088/1748-3182/7/2/025009] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
A biologically inspired navigation system for the mobile rat-like robot named Psikharpax is presented, allowing for self-localization and autonomous navigation in an initially unknown environment. The ability of parts of the model (e.g. the strategy selection mechanism) to reproduce rat behavioral data in various maze tasks has been validated before in simulations. But the capacity of the model to work on a real robot platform had not been tested. This paper presents our work on the implementation on the Psikharpax robot of two independent navigation strategies (a place-based planning strategy and a cue-guided taxon strategy) and a strategy selection meta-controller. We show how our robot can memorize which was the optimal strategy in each situation, by means of a reinforcement learning algorithm. Moreover, a context detector enables the controller to quickly adapt to changes in the environment-recognized as new contexts-and to restore previously acquired strategy preferences when a previously experienced context is recognized. This produces adaptivity closer to rat behavioral performance and constitutes a computational proposition of the role of the rat prefrontal cortex in strategy shifting. Moreover, such a brain-inspired meta-controller may provide an advancement for learning architectures in robotics.
Collapse
Affiliation(s)
- K Caluwaerts
- Institut des Systèmes Intelligents et de Robotique (ISIR), Université Pierre et Marie Curie, 4 place Jussieu, 75005 Paris, France.
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Lamarche-Vadel A, Blondel B, Truffer P, Burguet A, Cambonie G, Selton D, Arnaud C, Lardennois C, du Mazaubrun C, N'Guyen S, Mathis J, Bréart G, Kaminski M. Re-hospitalization in infants younger than 29 weeks' gestation in the EPIPAGE cohort. Acta Paediatr 2004; 93:1340-5. [PMID: 15499955 DOI: 10.1080/08035250410032926] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
AIM To estimate the re-hospitalization rate of extremely preterm children during infancy and associated factors after the recent improvement in survival rates. METHOD The cohort included all children born before 29 wk of gestation in nine French regions in 1997. All admissions between discharge from initial hospitalization and 9 mo after birth were considered. Factors studied included the child's characteristics at birth and during neonatal hospitalization, risk factors for infection after discharge and parents' socio-demographic characteristics. Adjusted odds ratios (aOR) for re-hospitalization for all reasons and for respiratory disorders were obtained from logistic regression models. RESULTS Of the 376 children, 178 were re-admitted at least once (47.3%; 95% CI: 42.3-52.4). Fifty-five percent of the hospitalized children were admitted at least once for respiratory disorders. The re-hospitalization rate was higher for children who had had chronic lung disease (aOR: 2.2; 95% CI: 1.3-3.7), those initially discharged between August and October (aOR: 2.5; 95% CI: 1.2-5.1) or between November and January (aOR: 3.2; 95% CI: 1.5-6.8), and children living with other children under six (aOR: 3.4; 95 %CI: 1.6-7.5). Re-hospitalizations were associated with neither gestational age nor the duration of neonatal hospitalization. Adjusted odds ratios for re-hospitalization for respiratory tract disorders were very similar to those for the overall hospitalizations. CONCLUSION Infants born before 29 wk have a very high risk of re-hospitalization. The associated factors can help define high-risk groups at discharge from the neonatal unit who need special surveillance.
Collapse
Affiliation(s)
- A Lamarche-Vadel
- Research Unit on Perinatal Health and Women's Health, INSERM U149, Villejuif, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Rozé JC, N'Guyen S, Bureau-Rouger V, Beucher A, Gosselin J, Amiel-Tison C. Réseau de suivi des nouveau-nés à risque de développer un handicap : l’exemple du réseau « Grandir ensemble en Pays-de-la-Loire ». ACTA ACUST UNITED AC 2004; 33:S54-60. [PMID: 14968020 DOI: 10.1016/s0368-2315(04)96666-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Newborns are given attentive perinatal care but the organization of further follow-up can be haphazard. The main consequences are the difficulties parents have in finding appropriate medical assistance for caring for high-risk infants and the absence of appropriate surveillance or efficient care. An inpatient-outpatient healthcare network enables early care of these infants and can reduce the consequences of neurosensorial sequelae. The overall impact of the regional perinatal care can also be evaluated. Such a network has been implemented in the Pays de Loire region in France since early 2003. In six months, among 1000 initially included infants, 500 were followed by pediatricians working in an outpatient (40%) or inpatient (60%) setting. This organization enables correction of over-centralization of neonatal care and the absence of coordination for follow up.
Collapse
Affiliation(s)
- J-C Rozé
- Service de Néonatalogie, Hôpital Mère-Enfant, CHU de Nantes
| | | | | | | | | | | |
Collapse
|
7
|
Debillon T, N'Guyen S, Muet A, Quere MP, Moussaly F, Roze JC. Limitations of ultrasonography for diagnosing white matter damage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2003; 88:F275-9. [PMID: 12819157 PMCID: PMC1721566 DOI: 10.1136/fn.88.4.f275] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To compare the accuracy of ultrasonography (US) and magnetic resonance imaging (MRI) in diagnosing white matter abnormalities in preterm infants and to determine the specific indications for MRI. DESIGN Prospective cohort study. SETTING A neonatal intensive care unit in France. PATIENTS All preterm infants (</= 33 weeks gestation) without severe respiratory distress syndrome precluding MRI. MAIN OUTCOME MEASURES US and MRI performed contemporaneously during the third postnatal week were analysed by an independent observer. The findings were compared with those of a term MRI scan, the results of which were taken as the final diagnosis. Statistical analysis was performed to determine which early imaging study best predicted the term MRI findings. RESULTS The early US and MRI findings (79 infants) correlated closely for severe lesions (cystic periventricular leucomalacia and parenchymal infarction; kappa coefficient = 0.86) but not for moderate lesions (non-cystic leucomalacia and parenchymal punctate haemorrhages; kappa = 0.62). Overall, early MRI findings predicted late MRI findings in 98% of patients (95% confidence interval (CI) 89.5 to 99.9) compared with only 68% for early US (95% CI 52.1 to 79.2). CONCLUSIONS US is highly effective in detecting severe lesions of the white matter in preterm infants, but MRI seems to be necessary for the diagnosis of less severe damage. MRI performed at about the third week of life is highly predictive of the final diagnosis at term.
Collapse
MESH Headings
- Age Factors
- Brain Infarction/diagnosis
- Brain Infarction/diagnostic imaging
- Brain Injuries/diagnosis
- Brain Injuries/diagnostic imaging
- Echoencephalography
- Humans
- Infant, Low Birth Weight
- Infant, Newborn
- Infant, Premature
- Infant, Premature, Diseases/diagnosis
- Infant, Premature, Diseases/diagnostic imaging
- Intensive Care, Neonatal
- Leukomalacia, Periventricular/diagnosis
- Leukomalacia, Periventricular/diagnostic imaging
- Magnetic Resonance Imaging
- Predictive Value of Tests
- Prospective Studies
- Sensitivity and Specificity
Collapse
Affiliation(s)
- T Debillon
- Neonatal Intensive Care Unit, University Hospital, Nantes, France.
| | | | | | | | | | | |
Collapse
|
8
|
Desguerre I, Pinton F, Nabbout R, Moutard ML, N'Guyen S, Marsac C, Ponsot G, Dulac O. Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 2003; 34:265-9. [PMID: 14598233 DOI: 10.1055/s-2003-43258] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
PURPOSE To report three cases of infantile spasms (IS) with an abnormal magnetic resonance imaging signal in the basal ganglia (Leigh-like syndrome), due to T8993G mt DNA mutation. PATIENTS AND RESULTS The first sign was, at the end of the first year of life, IS in one case and the combination of IS with behavior changes in the two other cases. Video EEG polygraphy demonstrated both spasms and hypsarrhythmia, but no other kind of seizures. Vigabatrin or steroids controlled the spasms with a follow-up of several years. All 3 patients had hyperlactatorrhachia (3.47 to 7 mmol/l). Axial hypotonia and dystonia appeared by the end of the first year of life. As in cases with the NARP mutation and onset later in life, neuropathy and retinopathy could also be demonstrated. DISCUSSION Although it is well established that symptomatic IS with hypsarrhythmia mainly result from cortical lesions, this epileptic encephalopathy may also be generated by lesions in the basal ganglia without evidence of cortical damage. This finding suggests that West syndrome is likely to be caused by age-related dysfunction at any level of a cortico-putaminal loop of hyperexcitability.
Collapse
Affiliation(s)
- I Desguerre
- Service de Neuropédiatrie, Hôpital Saint Vincent de Paul, 74 Avenue Denfert-Rochereau, 75014 Paris, France.
| | | | | | | | | | | | | | | |
Collapse
|